Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis

A. C. Huntley, Roslyn Rivkah Isseroff

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


A randomized, double-blind study compared the efficacy and safety of amcinonide and betamethasone dipropionate ointments, applied twice daily for two weeks, in the treatment of patients with moderate to severe psoriasis. Thirty-four patients were enrolled; thirty patients had had psoriasis for more than one year, and in the majority of patients, it was stable or slowly exacerbating. Significant improvement from baseline was observed with both ointments at weeks 1 and 2. The two drugs showed comparable cosmetic acceptability. Adverse cutaneous symptoms experienced were burning (both groups), itching (amcinonide), and stinging (betamethasone); no serious adverse effects were reported.

Original languageEnglish (US)
Pages (from-to)489-492
Number of pages4
Issue number5
StatePublished - 1985

ASJC Scopus subject areas

  • Dermatology
  • Immunology and Allergy


Dive into the research topics of 'Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis'. Together they form a unique fingerprint.

Cite this